Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 137
Filter
1.
Hernia ; 26(2): 599-608, 2022 04.
Article in English | MEDLINE | ID: mdl-34432175

ABSTRACT

PURPOSE: Post-pregnancy abdominal rectus diastasis (ARD) has raised attention in the field of surgery in recent years, but there is no consensus about when to consider surgery. Our aim was to find out what is the normal inter-rectus distance in fertile aged, female population in Finland and to examine whether there is a linea alba width that would predispose to diastasis-related problems after pregnancy. METHODS: For this prospective cohort study, women participating early pregnancy ultrasound in Helsinki University Hospital Department of Obstetrics and Gynecology during 1.1.2018-8.3.2019, were recruited. The width of linea alba was measured by ultrasound during the early pregnancy ultrasound. Symptoms were measured by questionnaire including Health-Related Quality of Life (RAND-36) and Oswestry Disability Index for back symptoms and disability. RESULTS: Linea alba width was measured in total of 933 women. The average inter-rectus distance (IRD) among nulliparous women was 1.81 ± 0.72 cm. After one previous pregnancy, the average linea alba width was 2.36 cm ± 0.83 cm and after more pregnancies 2.55 ± 1.09 cm. There was a positive correlation between previous pregnancies and the increased linea alba width (p = 0.00004). We did not perceive any threshold value of linea alba width that would predispose to back pain or movement control problems in this cohort, in which severe diastasis (over 5 cm) was rare. CONCLUSION: Mean inter-rectus distance in parous population exceeds stated normative values. Moderate ARD (3.0-5.0 cm) alone does not seem to explain low back pain or functional disability in population level. Severe post-pregnancy diastasis (over 5.0 cm) is rare.


Subject(s)
Diastasis, Muscle , Aged , Cohort Studies , Diastasis, Muscle/epidemiology , Diastasis, Muscle/surgery , Female , Finland/epidemiology , Herniorrhaphy , Humans , Male , Pregnancy , Prevalence , Prospective Studies , Quality of Life , Rectus Abdominis/diagnostic imaging , Rectus Abdominis/surgery
2.
Community Dent Health ; 36(2): 131-136, 2019 05 30.
Article in English | MEDLINE | ID: mdl-31021564

ABSTRACT

OBJECTIVES: To determine the direct and indirect costs of accessing and utilizing dental services in Tanzania and the proportion of patients experiencing economic burden due to treatment costs. BASIC RESEARCH DESIGN: Survey of 489 dental patients utilizing an out-of-pocket payment modality was carried out in four regional hospitals. Direct and indirect costs for service utilization were calculated. Financial expenditures were used to assess significant financial impacts of utilization of dental services on household economies. RESULTS: Direct costs comprised 80% of the total treatment costs, whereas indirect costs comprised 20%. About half of the patients experienced significant financial impacts as a result of their utilization of dental services. Proportionately more patients from low-income households (92.2%) experienced significant financial impacts. Most patients attended the clinics due to toothache and the most widely expected treatment was dental extraction. Only 7.1% of the patients received a filling. The costs for dental restorations were three-times those for tooth extraction. CONCLUSIONS: Dental service utilization leads to significant financial impacts on many of the households in this setting. Increasing the rate of prepayment for health services and reducing income inequality may help to mitigate these impacts.


Subject(s)
Dental Care , Health Expenditures , Health Services Accessibility , Dental Care/economics , Family Characteristics , Humans , Socioeconomic Factors , Tanzania
3.
Community Dent Health ; 35(3): 167-172, 2018 Aug 30.
Article in English | MEDLINE | ID: mdl-30106521

ABSTRACT

OBJECTIVES: To determine and compare patients' willingness-to-pay (WTP) for tooth extraction and filling services in Tanzania and to assess the socio-demographic factors that are associated with such valuations. METHODS: Contingent valuation survey utilizing an open-ended willingness-to-pay format was administered among 1522 outpatients in four regional hospitals in Tanzania. WTP for extraction and tooth filling services for various tooth categories were determined and compared using Mann-Whitney and Kruskal-Wallis tests. The association of WTP values with socio-demographic background factors was assessed using multiple regression analysis. RESULTS: The mean WTP amounts for tooth filling were Tanzania shillings (Tshs) 7,398 (3.4 US$) and Tshs 7,726 (3.5 US$) for anterior and posterior teeth respectively. The mean WTP for tooth filling services was lower than the average charged fees in dental facilities. The mean WTP amounts for tooth extraction were Tshs 5,448 (2.5 US$) and Tshs 6,188 (2.8 US$) for anterior and posterior teeth respectively. WTP amounts were shown to vary by age, income, outpatient status and previous experience with the dental services. Belonging in youngest age group (18-24 years) and having a high-income level was associated with increased odds for high WTP valuations irrespective of tooth and treatment types. CONCLUSIONS: WTP reveals a preference for tooth filling rather than extraction services in this population. More studies are needed to address the discrepancy between the stated preferences and utilization patterns for dental services.


Subject(s)
Dental Care/economics , Developing Countries , Financing, Personal , Adolescent , Adult , Humans , Middle Aged , Surveys and Questionnaires , Tanzania , Young Adult
4.
Neuropharmacology ; 141: 76-88, 2018 10.
Article in English | MEDLINE | ID: mdl-30138694

ABSTRACT

Abnormal protein kinase C (PKC) function contributes to many pathophysiological processes relevant for Alzheimer's disease (AD), such as amyloid precursor protein (APP) processing. Phorbol esters and other PKC activators have been demonstrated to enhance the secretion of soluble APPα (sAPPα), reduce the levels of ß-amyloid (Aß), induce synaptogenesis, and promote neuroprotection. We have previously described isophthalate derivatives as a structurally simple family of PKC activators. Here, we characterised the effects of isophthalate derivatives HMI-1a3 and HMI-1b11 on neuronal viability, neuroinflammatory response, processing of APP and dendritic spine density and morphology in in vitro. HMI-1a3 increased the viability of embryonic primary cortical neurons and decreased the production of the pro-inflammatory mediator TNFα, but not that of nitric oxide, in mouse neuron-BV2 microglia co-cultures upon LPS- and IFN-γ-induced neuroinflammation. Furthermore, both HMI-1a3 and HMI-1b11 increased the levels of sAPPα relative to total sAPP and the ratio of Aß42/Aß40 in human SH-SY5Y neuroblastoma cells. Finally, bryostatin-1, but not HMI-1a3, increased the number of mushroom spines in proportion to total spine density in mature mouse hippocampal neuron cultures. These results suggest that the PKC activator HMI-1a3 exerts neuroprotective functions in the in vitro models relevant for AD by reducing the production of TNFα and increasing the secretion of neuroprotective sAPPα.


Subject(s)
Alzheimer Disease/enzymology , Phthalic Acids/pharmacology , Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/metabolism , Animals , Bryostatins/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Coculture Techniques , Dendritic Spines/drug effects , Enzyme Activators/pharmacology , Hippocampus/metabolism , Humans , Mice , Microglia/metabolism , Neurons/drug effects , Nitric Oxide/metabolism , Peptide Fragments/metabolism , Phthalic Acids/chemistry , Primary Cell Culture , Tumor Necrosis Factor-alpha/metabolism
5.
Br J Surg ; 104(10): 1355-1361, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28677879

ABSTRACT

BACKGROUND: An increasing amount of evidence supports antibiotic therapy for treating uncomplicated acute appendicitis. The objective of this study was to compare the costs of antibiotics alone versus appendicectomy in treating uncomplicated acute appendicitis within the randomized controlled APPAC (APPendicitis ACuta) trial. METHODS: The APPAC multicentre, non-inferiority RCT was conducted on patients with CT-confirmed uncomplicated acute appendicitis. Patients were assigned randomly to appendicectomy or antibiotic treatment. All costs were recorded, whether generated by the initial visit and subsequent treatment or possible recurrent appendicitis during the 1-year follow-up. The cost estimates were based on cost levels for the year 2012. RESULTS: Some 273 patients were assigned to the appendicectomy group and 257 to antibiotic treatment. Most patients randomized to antibiotic treatment did not require appendicectomy during the 1-year follow-up. In the operative group, overall societal costs (€5989·2, 95 per cent c.i. 5787·3 to 6191·1) were 1·6 times higher (€2244·8, 1940·5 to 2549·1) than those in the antibiotic group (€3744·4, 3514·6 to 3974·2). In both groups, productivity losses represented a slightly higher proportion of overall societal costs than all treatment costs together, with diagnostics and medicines having a minor role. Those in the operative group were prescribed significantly more sick leave than those in the antibiotic group (mean(s.d.) 17·0(8·3) (95 per cent c.i. 16·0 to 18·0) versus 9·2(6·9) (8·3 to 10·0) days respectively; P < 0·001). When the age and sex of the patient as well as the hospital were controlled for simultaneously, the operative treatment generated significantly more costs in all models. CONCLUSION: Patients receiving antibiotic therapy for uncomplicated appendicitis incurred lower costs than those who had surgery.


Subject(s)
Anti-Bacterial Agents/economics , Anti-Bacterial Agents/therapeutic use , Appendectomy/economics , Appendicitis/drug therapy , Appendicitis/surgery , Acute Disease , Adolescent , Adult , Cost-Benefit Analysis , Ertapenem , Finland , Humans , Length of Stay/economics , Levofloxacin/economics , Levofloxacin/therapeutic use , Metronidazole/economics , Metronidazole/therapeutic use , Middle Aged , Recurrence , Sick Leave/economics , Treatment Outcome , Young Adult , beta-Lactams/economics , beta-Lactams/therapeutic use
6.
Appl Radiat Isot ; 118: 258-265, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27693738

ABSTRACT

99mTc-tricarbonyl-vardenafil was specifically radiosynthesized for diagnostic evaluation of erectile dysfunction with a radiochemical yield ~97.2%. It was stable in saline up to 15h and in serum for more than 6h. The radiocomplex was lipophilic with a partition coefficient ~1.32 and plasma protein binding 72-76%. Its structure was determined using molecular mechanics and confirmed by NMR. In-silico docking to its target PDE5 enzyme was performed. The radiocomplex inhibitory activity was assessed and its IC50 was 0.7nM. Biodistribution in normal rats and biological evaluation in rat models of erectile dysfunction were performed. The results strongly suggested that 99mTc-tricarbonyl-vardenafil is a good candidate to image erectile dysfunction in humans.


Subject(s)
Erectile Dysfunction/diagnostic imaging , Erectile Dysfunction/metabolism , Molecular Docking Simulation , Technetium/chemistry , Vardenafil Dihydrochloride/chemistry , Vardenafil Dihydrochloride/pharmacokinetics , Animals , Binding Sites , Computer Simulation , Drug Monitoring/methods , Erectile Dysfunction/drug therapy , Isotope Labeling/methods , Male , Metabolic Clearance Rate , Phosphodiesterase 5 Inhibitors/chemistry , Phosphodiesterase 5 Inhibitors/pharmacokinetics , Protein Binding , Radiopharmaceuticals/chemical synthesis , Radiopharmaceuticals/pharmacokinetics , Rats , Rats, Sprague-Dawley , Theranostic Nanomedicine/methods , Tissue Distribution
7.
Acta Anaesthesiol Scand ; 60(4): 450-6, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26742816

ABSTRACT

BACKGROUND: Easily accessible reliable information is crucial for strategic and tactical decision-making on operative processes. We report development of an analysis tool and resulting metrics for benchmarking purposes at a Finnish university hospital. METHODS: The analysis tool is based on data collected in a resource management system and an in-house cost-reporting database. RESULTS: The exercise reports key metrics for four operative service units and six surgical units from 2014 and the change from year 2013. Productivity, measured as total costs per total hours, ranged from 658 to 957 €/h and utilization of the total available resource hours at the service unit level ranged from 66% to 74%. The lowest costs were in a unit running only regular working hour shifts, whereas the highest costs were in a unit operating on 24/7 basis. The tool includes additional metrics on operating room (OR) scheduling and monthly data to support more detailed analysis. CONCLUSION: This report provides the hospital management with an improved and detailed overview of its operative service units and the surgical process and related costs. The operating costs are associated with on call duties, size of operative service units, and the requirements of the surgeries. This information aids in making mid- to long range decisions on managing OR capacity.


Subject(s)
Benchmarking , Efficiency , Surgical Procedures, Operative/economics , Appointments and Schedules , Health Care Costs , Humans , Operating Rooms/economics
8.
Scand J Rheumatol ; 45(4): 294-8, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26681432

ABSTRACT

OBJECTIVES: The aims of this study were to determine the within-patient variation in the duration of morning stiffness (MS) over 1 year and the corresponding monetary equivalents assigned to its changes using the willingness-to-pay (WTP) methodology. METHOD: A sample of 100 patients with rheumatoid arthritis (RA) was drawn from the register of the Hospital District of Southwest Finland. Subjects were interviewed by telephone on recruitment and 1 year later, using the same structured questionnaire. The subjects were asked to estimate in minutes the typical duration of their MS during the previous week. Sociodemographic background data and subjects' WTP for a 25, 50, 75, and 100% reduction in MS duration were requested, and years with RA diagnosis and serological data were obtained from hospital records. RESULTS: After 1 year, there was a reduction in average MS duration from 44.7 min to 39.0 min (ns); duration was reduced in 35% of patients, unchanged in 35%, and prolonged in 30%. Changes in MS duration were reflected by within-patient variation in WTP estimates. In linear regression models, change in duration of MS significantly (p < 0.03) explained the variation in change of WTP for symptom reduction. CONCLUSIONS: WTP methodology produces consistent monetary values to assess the relative values patients with RA place on reduction in duration of MS.


Subject(s)
Arthritis, Rheumatoid/physiopathology , Aged , Arthritis, Rheumatoid/economics , Circadian Rhythm , Cost-Benefit Analysis , Female , Finland , Humans , Linear Models , Male , Middle Aged , Surveys and Questionnaires
9.
Dermatol Ther (Heidelb) ; 4(1): 115-24, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24865468

ABSTRACT

INTRODUCTION: Psoriasis results in expenses to patients from many cost sources. Psoriasis treatments may result in considerable time and traveling costs, yet many studies fail to account for these costs. The objective of this study was to evaluate the multidimensional economic burden of psoriasis to patients. METHODS: The study was based on 232 Finnish patients with psoriasis or psoriatic arthritis visiting a tertiary level dermatological clinic during a 1-year study period between October 1, 2009 and September 30, 2010. The data were based on a patient questionnaire, clinical data from the medical records and reimbursement data from the Finnish Social Insurance Institution. Item costs were based on true costs charged from the patients and all time cost estimates were based on the Human Capital Approach method. RESULTS: 199 patients with psoriasis and 33 with psoriatic arthritis were included in the study. Total costs were higher for patients receiving traditional systemic medications or phototherapy than those not receiving such treatment. Travel costs and travel time costs accounted for more than 60% of the costs of phototherapy. Skin care at home was time consuming and thus caused significant burden to patients. The majority of the visit costs arose from hospital visits and only a small proportion were attributed to visiting primary health care providers. CONCLUSION: Visit charges and other patient co-payments were estimated to play a minor role in the total cost of psoriasis incurred by patients, while travel costs and lost time comprised the majority of the costs, which should not be omitted in future studies regarding costs of treatments.

10.
Article in Russian | MEDLINE | ID: mdl-23011431

ABSTRACT

Catechol-O-methyltransferase (COMT) remains an important regulatory element in prefrontal cortex dopamine homeostasis. The literature data suggest that individual differences in COMT activity (Val158Met polymorphism) might have indirect downstream effects on the reward system. The aim of the present study was to examine whether COMT deletion affects reinforcing effects of cocaine in mice. The study was conducted in male mice with homozygous COMT deletion as well as their C57BL/6J wild-type littermates. Animals were trained to nose-poke to receive response-contingent intravenous infusions of cocaine (0.3 mg/kg per infusion; final schedule of reinforcement - fixed ratio (FR) 3 time out 30 s). Following the initial acquisition phase, cocaine self-administration dose-effect functions (0.03, 0.1, 0.3, 1, and 3 mg/kg per infusion) were determined under FR3 and progressive ratio (PR) schedules of reinforcement. Cocaine dose-dependently maintained responding under FR3 and PR schedule of reinforcement when the unit dose of cocaine was varied across the sessions. The total cocaine intake did not differ in COMT deletion mice and wild-type mice. The results of this study suggest that individual differences in COMT activity do not affect primary reinforcing effects of cocaine in mice.


Subject(s)
Catechol O-Methyltransferase/deficiency , Cocaine/administration & dosage , Reinforcement, Psychology , Animals , Catechol O-Methyltransferase/genetics , Dose-Response Relationship, Drug , Male , Methionine/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Polymorphism, Genetic , Valine/genetics
11.
Scand J Rheumatol ; 41(6): 438-41, 2012.
Article in English | MEDLINE | ID: mdl-22994945

ABSTRACT

OBJECTIVES: To determine the variation in morning symptoms and in the corresponding monetary equivalents assigned to their reduction. METHODS: The sampled (n = 100) rheumatoid arthritis (RA) patients were interviewed twice by a trained interviewer using the same interview, 2 weeks apart. Patients assessed fatigue, pain, and severity of morning stiffness (MS) on waking up and after maximum improvement on a numeric rating scale (NRS). Patients estimated the duration of MS in minutes and reported the number of tender and swollen joints. Patients were also asked to estimate how much they would be willing to pay on a daily basis if pain, duration of MS, and severity of MS when waking up could be reduced by 25, 50, 75, and 100%. Weighted averages of the monetary assessments for symptom reduction were computed. RESULTS: On average, the NRS values at the first and second assessments were close to each other, except for fatigue and pain, which were significantly lower (p < 0.01) in the second assessment. There was limited within-patient variation, with the majority of symptom assessments within a range of ±10%. Weighted average willingness-to-pay (WTP) estimates were consistent across time points for reduction in pain and MS severity and duration. Changes in symptom assessments were reflected in the WTP estimates. CONCLUSIONS: The duration and severity of MS seemed to be more consistent over time than pain and fatigue. WTP estimates and their changes corresponded closely to changes in symptom assessments.


Subject(s)
Arthritis, Rheumatoid/physiopathology , Fatigue/physiopathology , Fees, Medical , Joints/physiopathology , Pain/physiopathology , Symptom Assessment/economics , Adult , Female , Humans , Male , Pain Measurement , Severity of Illness Index
12.
Bioorg Khim ; 38(2): 214-22, 2012.
Article in Russian | MEDLINE | ID: mdl-22792725

ABSTRACT

Nicotinic acetylcholine receptors (nAChRs) are implicated in the regulation ofintracellular Ca2+-dependent processes in cells both in normal and pathological states, alpha-Conotoxins isolated from Conus snails venom are a valuable tool for the study of pharmacological properties and functional role of nAChRs. In the present study the alpha-conotoxin MII analogue with the additional tyrosine attached to the N terminus (Y0-MII) was prepared. Also we synthesized analogs with the N-terminal glycine residue labeled with the Bolton- Hunter reagent (BH-MII) or fluorestsein isothiocyanate (FITC-MII). Fluorescence microscopy studies of the neuroblastoma SH-SY5Y cells loaded with Ca2+ indicator Fura-2 or with Ca2+ and Na+ indicators Fluo-4 and SBFI were performed to examine effect of MII modification on its ability to inhibit nicotin-induced increases in intracellular free Ca2+ and Na+ concentrations ([Ca2+] and [Na+]i respectively). Monitoring of individual cell [Ca2+]i and [Na+]i signals revealed different kinetics of [Ca2+]i and [Na+]i rise and decay in responses to brief nicotine (Nic) applications (10-30 microM, 3-5 min), which indicates to different mechanisms of Ca2+ and Na+ homeostasis control in SH-SY5Y cells. MII inhibited in concentration-dependent manner the both [Ca2+]i and [Na+]i increase induced by Nic. Additional tyrosine in the Y0-MII or, especially, more sizeable label in FITC-MII significantly reduced the inhibitory effect of MII. Whereas the efficiency of the Ca2+ response inhibition by BH-MII was found to be close to the efficiency of its inhibition by natural alpha-conotoxin MII, radioiodinated derivatives BH-MII can be used in radioligand assay.


Subject(s)
Calcium Signaling/drug effects , Calcium/metabolism , Conotoxins/pharmacology , Neuroblastoma/metabolism , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Sodium/metabolism , Cell Line, Tumor , Humans , Neoplasm Proteins/agonists , Neoplasm Proteins/metabolism , Neuroblastoma/pathology , Receptors, Nicotinic/metabolism
13.
Scand J Rheumatol Suppl ; 125: 12-6, 2011.
Article in English | MEDLINE | ID: mdl-21529305

ABSTRACT

OBJECTIVE: The aim of this study was to determine the monetary equivalent of the emotional and functional impact of morning stiffness (MS) in patients with rheumatoid arthritis (RA), using alternative valuing methods. METHODS: Telephone interviews were conducted among 166 patients with RA to assess utility and clinical symptoms, including MS. Three standard economic methods were used: the human capital approach (HCA), marginal value of time (MVT), and willingness-to-pay (WTP). RESULTS: The monetary equivalent of the impact of MS varied with the method used (from EUR 5.74 to EUR 17.87 per patient per day) and severity of MS (5-8-fold higher in patients with severe MS compared with mild MS). Patients placed considerable value on a reduction in duration and severity of MS. Patients with MS lasting an hour or more were willing to pay EUR 21.74/day to stop the symptom and EUR 10.63/day to halve the duration. Patients with severe MS were willing to pay EUR 47.86/day to stop the symptom and EUR 21.68/day to halve the severity. CONCLUSIONS: The observed variation in the monetary equivalent of the impact of MS obtained with the three estimation methods indicates that the findings of studies using different valuing methods should not be compared directly. The study demonstrates that a reduction in MS is worth a considerable amount to patients with RA, particularly those with severe or prolonged MS. These findings suggest that clinical treatment decisions to improve patients' quality of life should also incorporate therapy that reduces MS.


Subject(s)
Arthritis, Rheumatoid/physiopathology , Arthritis, Rheumatoid/psychology , Circadian Rhythm , Cost of Illness , Aged , Arthritis, Rheumatoid/economics , Arthritis, Rheumatoid/therapy , Female , Health Care Costs , Humans , Interviews as Topic , Male , Middle Aged , Patient Acceptance of Health Care , Severity of Illness Index , Sickness Impact Profile
14.
J Neurosci Methods ; 194(1): 122-31, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-20951734

ABSTRACT

In Parkinson's disease (PD) midbrain dopaminergic (DA) neurons degenerate and die, causing loss of motor function. Currently no therapies exist to ameliorate neurodegeneration or to restore DA neurons, although neurotrophic factors (NTFs) are promising leads. Prior in vivo studies the NTFs are routinely assessed in vitro by quantifying the survival of DA neurons from embryonic rodent midbrain cultures. Current in vitro methods are limited in terms of assay reliability, arduous workflow, low throughput, low statistical power and may obscure detection of molecules with minor yet critically important therapeutic effects. We have developed a medium-throughput, micro-island culture method. It permits analysis of 10-12 data points from a single embryo - several fold more than any previously published method - and enables comparisons of DA neurons from a single gene knockout (KO) embryo. It is computer-aided, improves statistical power and decreases the number of animals and workload per experiment. This method enhances testing capabilities of NTFs and other factors, and enables small scale screening of chemical drug libraries. We have validated the method by confirming the known effects of glial cell line-derived neurotrophic factor (GDNF) and neurturin (NRTN), and demonstrated additive effects via simultaneous addition of GDNF and heparin binding growth associated molecule (HB-GAM). We also show for the first time that DA neurons isolated from GDNF receptor RET-deficient mice are still GDNF responsive, suggesting the presence of an alternative non-RET receptor for GDNF in the DA system. Finally, the method can be adapted for analyses of other low abundance neuronal systems.


Subject(s)
Dopamine/physiology , Neurons/physiology , Animals , Antiparkinson Agents/pharmacology , Cell Count , Cell Size , Cells, Cultured , Cytological Techniques , Data Interpretation, Statistical , Drug Evaluation, Preclinical , Female , Glial Cell Line-Derived Neurotrophic Factor/pharmacology , Image Processing, Computer-Assisted , Immunohistochemistry , Mesencephalon/cytology , Mice , Mice, Knockout , Nerve Growth Factors/pharmacology , Neurites/physiology , Neurons/drug effects , Pregnancy , Proto-Oncogene Proteins c-ret/genetics , Superior Cervical Ganglion/cytology , Tyrosine 3-Monooxygenase/metabolism
15.
Inflamm Res ; 57(5): 230-40, 2008 May.
Article in English | MEDLINE | ID: mdl-18594783

ABSTRACT

OBJECTIVE AND DESIGN: Tristetraprolin (TTP) is a 3'-UTR-binding protein known to destabilize mRNAs of TNFalpha and some other cytokines and to act as an anti-inflammatory factor. The aim of this study was to investigate the role of classical protein kinase C isoenzymes (cPKC) in the regulation of TTP expression in activated macrophages. MATERIALS AND METHODS: The expression of TTP in J774 macrophages was induced by a combination of LPS and phorbol myristate acetate (PMA). The effects of cPKC inhibitors and the effects of cPKC activation and downregulation by PMA on TTP protein and mRNA expression were determined by Western blotting and quantitative RT-PCR, respectively. Also, the effect of PKC beta II inhibitor CGP53353 on the activation of transcription factors AP-2, NF-kappaB, EGR1 and Sp1 was assessed. RESULTS: cPKC inhibitors RO318220, GO6976, LY333531 and CGP53353 inhibited LPS and PMA-induced expression of TTP protein and mRNA. Similar effects were obtained when cPKC isoenzymes were downregulated by PMA. In addition, CGP53353 decreased the activation of transcription factor AP-2. CONCLUSIONS: The results suggest that cPKCs, most likely PKC beta II, upregulate TTP expression in activated macrophages. This regulation is possibly mediated through the activation of transcription factor AP-2, and serves as an additional mechanism how PKC beta regulates the inflammatory process.


Subject(s)
Macrophages/metabolism , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Tristetraprolin/metabolism , Animals , Carcinogens/pharmacology , Cells, Cultured , Early Growth Response Protein 1/metabolism , Enzyme Inhibitors/pharmacology , Immunoglobulins/metabolism , Isoenzymes/metabolism , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Mice , NF-kappa B/metabolism , Phthalimides/pharmacology , Protein Kinase C beta , RNA, Messenger/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Transcription Factor AP-2/metabolism , Tristetraprolin/drug effects
16.
Health Policy ; 70(1): 85-96, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15312711

ABSTRACT

BACKGROUND: Helicobacter pylori screening may markedly reduce mortality and morbidity in the decades ahead. AIMS: This study explores the costs and benefits of population-based H. pylori screening in terms of health care cost taking into account all relevant H. pylori-related diseases. MATERIAL AND METHODS: The computer-based decision analysis compared two strategies: (1) screen for H. pylori and treat those individuals who test positive, and (2) do not screen for H. pylori, and test and treat H. pylori only if related clinical symptoms appear. The model estimated the discounted H. pylori-related accumulative health care costs from screening age to death in both strategies. The baseline case estimates cost-benefit for screenees aged 15-45 years. The main outcome measure is the incremental health care cost per case in the screening compared with the no-screening alternative. The probability estimates were obtained from the Finnish Vammala H. pylori screen and treat project, including 5288 subjects in the years 1996-1998, published studies, national statistics and hospitals' internal accounts. RESULTS: The incremental cost per case was 26 US dollars in the screening compared with the no-screening alternative. It was lowest in the group aged 45 years, where H. pylori screening showed cost savings per case. CONCLUSIONS: H. pylori screening is more favourable in the older age cohorts. The estimated cost per screenee can be considered to be very acceptable if the current pathophysiological evidence on the potential effects of H. pylori eradication are confirmed in the future. However, there is uncertainty about the possible negative effect of eradicating H. pylori infection on gastro-esophageal reflux disease and esophageal adenocarcinoma. This could change the balance of benefits against risks of eradicating H. pylori infection.


Subject(s)
Cost-Benefit Analysis , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Mass Screening/economics , Adolescent , Adult , Finland , Health Policy , Humans , Middle Aged , Sensitivity and Specificity
17.
J Dent Res ; 82(9): 713-8, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12939356

ABSTRACT

Several earlier studies have suggested that development of coronary heart disease (CHD) is causally related to oral infections. The aim of this study was to investigate the association between oral health indicators and CHD deaths. Out of a nationally representative sample, 6527 men and women aged 30-69 years participated in the health examination with a dental check. Detailed oral health data included caries, periodontal and dental plaque status, presence of remaining teeth, and various types of dentures. Over a mean 12-year follow-up, persons dying of CHD were older and more often smoked, had hypertension, hypercholesterolemia, diabetes, and only a basic education compared with other persons. In univariate analyses, several oral health indicators were associated with CHD deaths. Adjustment for the established CHD risk factors reduced all these associations to statistical non-significance. The associations between oral health indicators and CHD are mostly explained by confounding factors, particularly those relating to health behavior.


Subject(s)
Coronary Disease/mortality , Health Status Indicators , Oral Health , Adult , Age Factors , Aged , Analysis of Variance , Confounding Factors, Epidemiologic , Dental Caries/epidemiology , Dental Plaque/epidemiology , Dentures/statistics & numerical data , Diabetes Mellitus/epidemiology , Educational Status , Female , Finland/epidemiology , Follow-Up Studies , Health Behavior , Humans , Hypercholesterolemia/epidemiology , Hypertension/epidemiology , Jaw, Edentulous, Partially/epidemiology , Male , Middle Aged , Periodontal Diseases/epidemiology , Smoking/epidemiology
18.
J Oral Rehabil ; 30(7): 743-8, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12791162

ABSTRACT

The aim of this study was to evaluate the oral health of elderly Finnish men wearing removable dentures supplied either by dentists, denturists or laboratory technicians. From a sample of 550 men, 362 subjects were both interviewed and clinically examined. The subjects were asked a range of questions related to their oral health and dentures. Clinical examinations were carried out by one dentist using well-defined criteria and without knowing the information the respective subjects had given in the interview. The 242 denture wearers had a higher frequency (P < 0.001) of mucous membrane lesions (78.7%) than the 120 non-wearers (27.5%). Differences between the denture providers were small, although subjects with dentures provided by dentists had less often most of the recorded mucous membrane lesions than other denture wearers. Coating of tongue and cheilitis angularis were the most commonly encountered lesions. High levels of yeast growth were observed more frequently (P < 0.02) among subjects who had obtained their dentures from dentists (41.3%) than from either denturists (17.1%) or laboratory technicians (18.2%). Among dentate subjects, the average number of remaining teeth was higher (P < 0.05) among those who had obtained their dentures from dentists (8.7) than among subjects wearing dentures from denturists (5.9) or laboratory technicians (6.2). Subjects wearing dentures supplied by dentists had slightly better oral health than other denture wearers. The observed differences can be at least partly explained by dentists' patients having higher number of remaining teeth and also more frequent check-up visits.


Subject(s)
Dental Technicians , Dentists , Denture Design/standards , Denture, Complete/standards , Oral Health/standards , Dental Care for Aged/standards , Denture, Partial, Removable/standards , Finland/epidemiology , Humans , Laboratories, Dental , Male
19.
J Oral Rehabil ; 30(4): 347-52, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12631157

ABSTRACT

The aim of this study was to evaluate the clinical quality of removable dentures of elderly Finnish men, which had been prepared either by dentists, denturists or dental laboratory technicians. The participants comprised 242 denture-wearing subjects, with 231 maxillary and 177 mandibular removable dentures which had been prepared either by dentists, denturists or dental laboratory technicians. Clinical examinations were carried out without the examining dentist knowing who had provided the dentures. Complete dentures which had been illegally provided by laboratory technicians had significantly poorer retention and fitted less well in tuber and alveolar areas than those provided by either dentists or denturists. Complete maxillary dentures which had been provided illegally by laboratory technicians had significantly (P < 0.01) higher occurrence (90%) of some unacceptable characteristics than those (43%) provided by dentists or denturists. The difference between complete mandibular dentures was also obvious, 86% versus 59%, although statistically non-significant. Of those partial maxillary dentures provided by dentists 53% had some unacceptable characteristics, compared with 80% of those illegally provided by denturists or laboratory technicians (NS). In the case of partial mandibular dentures, 36% of those provided by dentists and 32% of those by denturists or laboratory technicians had some unacceptable characteristic (NS). Illegal provision of removable dentures seemed to be related to decreased clinical quality.


Subject(s)
Dental Care for Aged/standards , Denture Design/standards , Denture, Complete/standards , Denture, Partial, Removable/standards , Aged , Aged, 80 and over , Dental Technicians , Denture Retention/standards , Denturists , Humans , Jaw, Edentulous, Partially , Laboratories, Dental , Male , Middle Aged , Patient Satisfaction
20.
J Oral Rehabil ; 30(1): 55-9, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12485384

ABSTRACT

In several countries removable dentures can be supplied by either dentists or denturists. Dental laboratory technicians, on the other hand, are licensed only to construct dentures on the prescription of a dentist and do not supply dentures directly to patients. This study investigates provision of dentures by dentists, denturists and laboratory technicians to 264 elderly Finnish World War II veterans. The veterans were wearing 454 removable dentures, of which 272 were complete dentures (CD) and 177 were removable partial dentures (RPD). Dentists had supplied one-quarter of the CD and three-quarters of the RPD, denturists had supplied two-thirds of the CD and one-fifth of the RPD, whereas the dental laboratory technicians had supplied the remaining seven per cent of the CD and four per cent of the RPD. Denturists had provided mainly mandibular partial dentures. A high proportion of the RPD provided illegally by denturists were made to oppose CD. The subjects reported that maxillary CD were good or very good more often than mandibular CD and considered more often CD by dentists or denturists good or very good than CD by dental laboratory technicians.


Subject(s)
Dental Technicians , Dentists , Denture, Partial, Removable , Aged , Aged, 80 and over , Denture Design , Denturists , Finland , Humans , Male , Middle Aged , Patient Satisfaction
SELECTION OF CITATIONS
SEARCH DETAIL
...